The polypropylene housing has a wide chemical compatibility! It is suitable for samples that are difficult to filter.
We would like to introduce the 'Glass Fiber Acrodisc Syringe Filter' for pre-filtration handled by Nippon Paul Co., Ltd. The Multi-Pre-Filter (GxF) offers 2 to 4 times the filtration performance compared to standard glass fiber products, reducing clogging. Since it is made of 100% borosilicate glass fiber without binders, there are no undesirable extracts. 【Features】 ■ Reduces clogging ■ The Multi-Pre-Filter (GxF) has 2 to 4 times the filtration performance compared to standard glass fiber products ■ Polypropylene housing offers broad chemical compatibility ■ The 37 mm size is suitable for pre-filtration of significantly contaminated samples *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Lineup (Partial)】 ■ Water-based / Organic (Dual-use) ・Acro LC13 "4457" ・Acro LC13 Mini Spike "4452" ■ For Ion Chromatography ・Ion Chromatography Acrodisc 13 "4485" ・Ion Chromatography Acrodisc 25 "4585" ■ Glass Fiber ・Glass Fiber Acrodisc 25 "4523" ・Glass Fiber Acrodisc 25 "4524" *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ For sample pretreatment ■ For pre-filtration *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
